During the past decade, Musculoskeletal Tumor Center of Peking University People's Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Musculoskeletal Tumor Center of Peking University People's Hospital" #1 collaborator was "Jiangsu HengRui Medicine Co., Ltd." with 1 trials as a collaborator, "Peking University International Hospital" with 1 trials as a collaborator, "Peking University Shougang Hospital" with 1 trials as a collaborator, "Second Affiliated Hospital, School of Medicine, Zhejiang University" with 1 trials as a collaborator and "Xijing Hospital" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Musculoskeletal Tumor Center of Peking University People's Hospital" are "Efficacy" (2 trials), "Survival" (2 trials), "Toxicity" (2 trials), "Clinical Benefit Rate" (1 trials) and "Histological Response" (1 trials). Many other conditions were trialed in "Musculoskeletal Tumor Center of Peking University People's Hospital" in a lesser frequency.

Most popular intervention types in "Musculoskeletal Tumor Center of Peking University People's Hospital" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Apatinib" (1 trials), "Apatinib Mesylate" (1 trials), "Methylsulfonic apatinib" (1 trials), "SHR-1210" (1 trials) and "all study participants" (1 trials). Other intervention names were less common.

The vast majority of trials in "Musculoskeletal Tumor Center of Peking University People's Hospital" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Musculoskeletal Tumor Center of Peking University People's Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Musculoskeletal Tumor Center of Peking University People's Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Musculoskeletal Tumor Center of Peking University People's Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".